1. Phosphodiesterase-4 Inhibitor Roflumilast-Mediated Protective Effect in Sepsis-Induced Late-Phase Event of Acute Kidney Injury: A Narrative Review
   Imran Kazmi et al, 2022, Pharmaceuticals CrossRef
2. A European pharmacotherapeutic agent roflumilast exploring integrated preclinical and clinical evidence for SARS CoV‐2 mediated inflammation to organ damage
   Yogendra Singh et al, 2022, British Journal of Clinical Pharmacology CrossRef
3. Elucidating the multifaceted roles of GPR146 in non-specific orbital inflammation: a concerted analytical approach through the prisms of bioinformatics and machine learning
   Zixuan Wu et al, 2024, Frontiers in Medicine CrossRef
4. Bioinformatic validation and machine learning-based exploration of purine metabolism-related gene signatures in the context of immunotherapeutic strategies for nonspecific orbital inflammation
   Zixuan Wu et al, 2024, Frontiers in Immunology CrossRef
5. The roles of IRF8 in nonspecific orbital inflammation: an integrated analysis by bioinformatics and machine learning
   Zixuan Wu et al, 2024, Journal of Ophthalmic Inflammation and Infection CrossRef
6. Roflumilast improves resolution of sepsis‐induced acute kidney injury by retarding late phase renal interstitial immune cells infiltration and leakage in urinary sediments
   Kirti Gupta et al, 2022, Fundamental & Clinical Pharmacology CrossRef
7. Transcription factor JDP2 activates PDE4B to participate in hypoxia/reoxygenation‑induced H9c2 cell injury
   Suipeng Li et al, 2022, Experimental and Therapeutic Medicine CrossRef
8. The regulatory role of PDE4B in the progression of inflammatory function study
   Yue Su et al, 2022, Frontiers in Pharmacology CrossRef